ARAF and colorectal carcinoma: These studies reveal a new paradigm in CRC whereby pks+ E. coli–infected CRC cells activate the c-MYC/miR-20a-5p/SENP1/senescence/growth factors pathway, consequently promoting the proliferation of uninfected cells and, in turn, stimulating tumor growth (Figure 3).